Cargando…

2309. Ceftaroline for Central Nervous System and Ocular Infections

BACKGROUND: Ceftaroline is increasingly used in combination therapy for methicillin resistant Staphylococcus aureus (MRSA) bacteremia. Animal models suggest ceftaroline penetrates the central nervous system (CNS) and vitreous humor; however, there are limited data which describe outcomes of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siegrist, Emily A, Sassine, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752239/ http://dx.doi.org/10.1093/ofid/ofac492.141

Ejemplares similares

Use of ceftaroline in complex central nervous system infections
por: Álvarez, Alicia Alonso, et al.
Publicado: (2023)

2309. Could Mean Platelet Volume Predict Platelet Count Recovery in Dengue Virus Infection?
por: Sanz, Ana M, et al.
Publicado: (2019)

1627. Antibiotic Use and Clinical Outcomes in Peripartum Infections
por: Siegrist, Emily A, et al.
Publicado: (2023)

2309. Promoting Healthcare Worker (HCW) Use of Personal Protective Equipment in Pediatric Ambulatory Settings
por: Odeniyi, Folasade, et al.
Publicado: (2018)

786. Ceftaroline and Avibactam? Is This a Potential Combination for Mycobacterium abscessus Infection?
por: Dousa, Khalid M, et al.
Publicado: (2018)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

PB2309: EVALUATION OF MORBIMORTALITY FACTORS OF PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
por: Pinto, M. I., et al.
Publicado: (2022)

Central Nervous System and Ocular Manifestations in Puumala Hantavirus Infection
por: Hautala, Nina, et al.
Publicado: (2021)

2309. Impact of Stopping Asymptomatic SARS-Co-V-2 Admission Testing: An Autoregressive Integrated Moving Average (ARIMA) Model Analysis at Stanford Healthcare, 2023
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2023)

731 Utility of Ceftaroline in the Treatment of Persistent Bacteremia and Deep-Seated Infections
por: Burgess, Donna R., et al.
Publicado: (2014)

In vitro Activity of Ceftaroline Against Pathogens Collected Globally from the AWARE Surveillance Program, 2016
por: Hackel, Meredith, et al.
Publicado: (2017)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

Systemic Oidiomycosis, with Manifestations in Central Nervous System
Publicado: (1917)

1969. Comparison of Adverse Event Rates Between Patients Treated With Ceftaroline or Ceftriaxone
por: Jansen, Jeffrey W, et al.
Publicado: (2018)

1543. Ceftaroline Model-based Dose Individualization in an Infant with Kidney Disease and Mediastinitis
por: Murphy, Mark, et al.
Publicado: (2019)

Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China
por: Li, Kemin, et al.
Publicado: (2017)

2793. Clinical Outcomes of Combination Therapy with Daptomycin and Ceftaroline for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Chapin, Ryan W, et al.
Publicado: (2023)

1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019)

472 Ceftaroline-induced Neutropenia: Two Case Reports
por: Martin, Kelly E., et al.
Publicado: (2014)

Viral Infections of the Central Nervous System in Qatar: Epidemiology, Pathogenesis and Clinical Outcomes
por: Abid, Fatma Ben, et al.
Publicado: (2017)

1302. HIV Testing in Adults Presenting with Central Nervous System (CNS) Infections
por: Ma, Bert, et al.
Publicado: (2019)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

1030. Epidemiology and Microbiologic Characteristics of Post-operative Central Nervous System Infections following Endoscopic Endonasal Surgery
por: Shah, Sunish, et al.
Publicado: (2022)

Treatment Outcomes and Adverse Drug Reactions Associated with Ceftaroline Use
por: Blumenthal, Kimberly, et al.
Publicado: (2015)

Ceftaroline in complicated skin and skin-structure infections
por: Hernandez, Paul O, et al.
Publicado: (2012)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

2426. Ceftaroline-Associated Neutropenia: Retrospective Study and Systematic Review of Incidence, Risk Factors, and Outcomes
por: Sullivan, Eva, et al.
Publicado: (2018)

1367. Reduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s HospitalReduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s Hospital
por: Sommer, Lauren, et al.
Publicado: (2020)

Temperature management in central nervous infection
por: Schmutzhard, Erich, et al.
Publicado: (2012)

678 Ceftaroline vs Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients
por: Nguyen, Hao, et al.
Publicado: (2014)

Antivirals With Activity Against Mpox: A Clinically Oriented Review
por: Siegrist, Emily A, et al.
Publicado: (2022)

Mucormycosis and COVID-19: manifestations of the central nervous system and the ocular system
por: Polo Martínez, Michelle Ariana, et al.
Publicado: (2022)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Ceftaroline Fosamil: A Brief Clinical Review
por: Shirley, Debbie-Ann T., et al.
Publicado: (2013)

836 Central Nervous System Infections Caused by Acinetobacter baumannii.
por: Kyrillos, Ramona, et al.
Publicado: (2014)

1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022)

1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults
por: Esquivel, Marc, et al.
Publicado: (2021)

190. Outcomes of Early Ceftaroline-based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia
por: Dolan, Mackenzie, et al.
Publicado: (2021)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_trtvd0tno9dgmfvlpm5hrak5im